Identification
Personal identification
- Full name
- Ana Bárbara de Sousa Carreira
- Gender
- Female
Citation names
- Carreira, Barbara
Author identifiers
- Ciência ID
- C017-F1FA-FB56
- ORCID iD
- 0000-0001-6382-5745
- Scopus Author Id
- 57195721985
Email addresses
- a.carreira@campus.ul.pt (Professional)
Knowledge fields
- Medical and Health Sciences - Basic Medicine - Pharmacology and pharmacy
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
Portuguese (Mother tongue) | |||||
English | Advanced (C1) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Advanced (C1) |
Education
Degree | Classification | |
---|---|---|
2017/10/01 - 2023/09/26
Concluded
|
Farmácia (Doutoramento)
Major in Tecnologia Farmacêutica
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Precision nanotechnology-based therapeutic approaches to enhance tumor-immune cells crosstalk within melanoma brain metastasis
stromal microenvironment" (THESIS/DISSERTATION)
|
Summa cum laude |
2018/10/01 - 2018/10/04
Concluded
|
IGC Course on Laboratory Animal Sciences in Mouse and Zebrafish (Outros)
Instituto Gulbenkian de Ciência, Portugal
|
|
2015/12
Concluded
|
Biotecnologia (Mestrado)
Major in Sem especialização
Universidade NOVA de Lisboa Faculdade de Ciências e Tecnologia, Portugal
"Mechanisms underlying intracellular delivery" (THESIS/DISSERTATION)
|
17 |
2013
Concluded
|
Licenciatura em Bioquímica (Licenciatura)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
""PCR optimization for incorporation in microfluidic systems" (Classificação final de 18 valores)" (THESIS/DISSERTATION)
|
14 valores |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2023/10 - Current | Researcher (Research) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2017/10 - 2023/09 | PhD student at Professor Helena F. Florindo Lab (iMedULisboa, Lisboa) and at Professor Ronit Satchi-Fainaro (Tel Aviv University), supported with a FCT scholarship | Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Tel Aviv University School of Medicine, Israel | ||
2022/06/01 - 2022/08/30 | Visiting PhD student at Professor Ronit Satchi-Fainaro Lab (Tel Aviv, Israel) | Sackler School of Medicine, Tel Aviv University, Israel |
Sackler School of Medicine, Tel Aviv University, Israel |
Projects
Grant
Designation | Funders | |
---|---|---|
2022 - 2024 | Multifunctional nano-immunotherapy for melanoma brain metastases treatment
PTDC/BTM-SAL/4350/2021
Research Fellow
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal Tel Aviv University, Israel |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2017 - 2023 | Precision nanotechnology-based therapeutic approaches to enhance tumor-immune cells crosstalk within melanoma stromal microenvironment
SFRH/BD/131969/2017
PhD Student Fellow
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Tel Aviv University, Israel |
Fundação para a Ciência e a Tecnologia
Concluded
|
Contract
Designation | Funders | |
---|---|---|
2024/02 - Current | Multifunctional nano-immunotherapy against breast brain metastases
LCF/PR/HR22/52420016
Post-doc
|
Ongoing
|
2022 - 2023 | Next-generation nanomaterials to sensitize breast cancer to immunotherapy
UTAP-EXPL/NPN/0041/2021
Researcher
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2022 - 2023 | New opportunities for small molecules in immuno-oncology
EXPL/MED-QUI/1316/2021
PhD Student Fellow
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2020 - 2023 | Development of a translational COVID-19 Vaccine
CF01-00014
Researcher
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
CaixaForum Barcelona
Concluded
|
2019 - 2022 | Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines
HR18-00589
Researcher
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Tel Aviv University, Israel Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe, Spain |
CaixaForum Barcelona |
2020 - 2021 | Nanomateriais para desenho de novas vacinas
UTA-EXPL/NPN/0082/2019
Researcher
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2017 - 2021 | Modulation of melanoma-stroma interactions using a rationally-designed nanomedicine combining BRAFi-, MEKi- and immune-therapies
ENMed/0051/2016
Researcher
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Tel Aviv University, Israel |
Fundação para a Ciência e a Tecnologia
Concluded
|
Outputs
Publications
Book chapter |
|
Conference abstract |
|
Conference poster |
|
Journal article |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2025/01 | Neoantigen Cancer Nanovaccine Against Melanoma Brain Metastases | 5th SPLC-CRS Young Scientists Meeting
(Barcelona, Spain)
|
2024/02 | Personalized neoantigen cancer nanovaccine to guide host immune response against melanoma brain metastases | XV Spanish-Portuguese Conference on Controlled Drug Delivery
(Lisbon, Portugal)
|
2023 | Nano-immunotherapy regulation of tumor-immune-stromal immunity blocks brain metastases dissemination | 7a Conferência da redeSAÚDE
(Lisbon, Portugal)
|
2023 | Nanotechnology-based cancer vaccine to re-educate host immune response against melanoma brain metastases | III ASPIC-ASEICA International Meeting
(Porto, Portugal)
|
2023 | Translational nanotechnology-based cancer nanovaccine to re-educate host immune response against melanoma brain metastases | 14th iMed.ULisboa Postgraduate Students Meeting
(Lisbon, Portugal)
|
2023 | Translational nanotechnology-based cancer nanovaccine to re-educate host immune response against melanoma brain metastases | EUFEPS Annual Meeting 2023
(Lisbon, Portugal)
|
2022 | Precision Nanomedicine-based Immunotherapy to Overcome Immunosuppression Against Melanoma Brain Metastasis | CRS 2022 Annual Meeting & Expo Advanced Delivery Science
(Monteral, Canada)
|
2021 | Precision Nanomedicine-based Immunotherapy to Overcome Immunosuppression Against Melanoma Brain Metastasis | 5a Conferência da redeSAÚDE
(Lisbon, Portugal)
|
2021 | Precision Multifunctional Nanomedicines to Regulate Immunosuppression Against Melanoma Brain Metastasis | Cutaneous Melanoma: From Where to Where?
(Lisbon, Portugal)
|
2020 | Precision nanomedicine-based therapeutics to regulate immunosuppresion against melanoma | XIIIth Spanish-Portuguese Conference on Controlled Drug Delivery
(Santiago de Compostela, Spain)
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2019/07/15 - 2019/07/16 | 11th iMed.ULisboa Postgraduate Students Meeting & 4rd i3DU Meeting (2019/07/15 - 2019/07/16)
Congress (President of the Organising Committee)
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2018 - 2018 | FLx Flow - Flow Cytometry Course covered basic and advanced cytometry topics and comprised lectures and practical modules
taught by national and international experts in the field. Cytometry applications offered at all levels, targeted at both
beginners
Other
|
FLx Flow - Flow Cytometry Course
Instituto Gulbenkian de Ciência, Portugal
|
Association member
Society Organization name | Role | |
---|---|---|
2020 - Current | Spanish-Portuguese Local Chapter Controlled Release Society | |
2019 - Current | European Association for Cancer Research (EACR) |
Distinctions
Award
2024 | MSD Poster Awardee
Merck Sharp & Dohme Corp, United States
|
2023 | Short-selected PhD competition
The European Federation for Pharmaceutical Sciences, Sweden
|
2023 | Nature Reviews Bioengineering Poster Prize
Nature Reviews Bioengineering , United States
|
2022 | Travel Fellowship for Research Exchange at Tel Aviv University
Federation of European Biochemical Societies, United Kingdom
|
2022 | Travel Fellowship for Research Exchange at Tel Aviv University
European Association For Cancer Research, United Kingdom
|
2019 | Travel Grant for Congress "17th Annual Meeting of the Association for Cancer Immunotherapy", 21-23 May, 2019, Mainz, Germany
Association for Cancer Immunotherapy, Germany
|